Hancock Jaffe Laboratories, Inc. — Form D/A

Hancock Jaffe Laboratories, Inc. of IRVINE, CA, a company, filed a Form D amendment with the SEC on 2019-05-03. The offering totals $2.7M, of which $2.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Francis A DuhayDirectorIrvine, CA
Yury ZhiviloDirectorIrvine, CA
Yury ZhiviloExecutive OfficerIrvine, CA
Robert AndersonDirectorVANCOUVER, A1
Sanjay ShrivastavaRelated PersonHayward, CA
WILLIAM ABBOTTExecutive OfficerMANSFIELD, MA
Yury ZhiviloRelated PersonIrvine, CA
Robert DoyleDirectorVancouver, A1
Francis C DuhayDirectorIrvine, CA
Robert Andrew BermanDirectorIrvine, CA
Robert Andrew BermanExecutive OfficerIrvine, CA
Robert C GrayDirectorIrvine, CA
Mark H GlickmanExecutive OfficerIrvine, CA
Sanjay Andrew ShrivastavaDirectorIrvine, CA
Craig Andrew GlynnExecutive OfficerIrvine, CA
Matthew M JenusaitisDirectorIrvine, CA
Robert A BermanDirectorIrvine, CA
Robert A BermanExecutive OfficerIrvine, CA
Sanjay A ShrivastavaDirectorIrvine, CA
Francis A Duhay, M.D.DirectorIrvine, CA
Marc H Glickman, M.D.Executive OfficerIrvine, CA
Robert H RankinExecutive OfficerIrvine, CA
Francis DuhayRelated PersonIrvine, CA
Benedict Broennimann, MDExecutive OfficerIrvine, CA
Gennady AlferenkoDirectorIrvine, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2020-08-04D$1.6M$1.6M
2020-03-10D$890K$650K
2019-04-16D$2.7M$2.7M
2017-06-26D$2.0M$1.0M
2017-03-22D$7.5M$194K
2015-12-15D$6.5M$680K

More